| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |